Wall Street Taking Notice of California Initiative To Lower Drug Prices; Drugmakers Pour $22 Million More Into Campaign To Defeat It
Carmen Balber, Consumer Watchdog | Oct 20, 2016 | California
'Medical fascism' or public safety? Lawmakers endure angry public during COVID misinformation bill hearing
By Eli Kirshbaum | Jun 30, 2022 | California
CHRT study shows effectiveness of MDHHS outreach methods to Medicaid members
By Patrick Jones | Jun 30, 2022 | Michigan
UT to expand safety and mental health resources for its student body
By Boram Kim | Jun 30, 2022 | Texas
Oregon education leaders discuss tools for curbing adolescent fentanyl use
By Shane Ersland | Jun 30, 2022 | Oregon
Medicare Only: Medicare Prior Authorization Effective July 1, 2022
By Sunshine Health | Jun 30, 2022 | Florida
Medicare projections from CBO and the program’s trustees
By James C. Capretta | Jun 14, 2022 | Federal
Divided California Assembly approves bill prohibiting COVID-19 misinformation from providers
By Eli Kirshbaum | Jun 2, 2022 | California
California Legislature advances controversial effort to restrict health sector consolidation
By Eli Kirshbaum | Jun 1, 2022 | California
Lawmakers push for greater availability of naloxone in Oregon
By Shane Ersland | Jun 2, 2022 | Oregon
Task force members concerned with software options under consideration for DOC’s new EHR system
By Shane Ersland | Jun 10, 2022 | Oregon